SS Innovations International Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $52.4M+153.8% YoYTTM through 30 Jun 2026
Net Income -$12.4MTTM through 30 Jun 2026
Free Cash Flow -$18.4MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 46.0% |
| EBITDA Margin | -13.7% |
| Operating Margin | -19.3% |
| Net Margin | -23.7% |
Returns
-31.7%ROE
-16.3%ROA
Balance Sheet Health
Debt / Equity0.30x
Current Ratio1.53x
Net Debt$8.2M
Cash & Equivalents$13.6M
Quality Metrics
Altman Z-Score8.95
Piotroski F-Score3 / 9
FCF Margin-35.1%
Rule of 40-21.7
Multi-Year Trend
RevenueFY2025: $42.5M
Diluted EPS-$0.06TTMFY2025: $-0.06
Dividend
No dividend
Capital Allocation
R&D Spend$5.6M
Capex Intensity5.4%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| India | $37M | View detailsContinued expansion of the SSi Mantra installed base in India while leveraging regulatory approvals to enter international markets. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.